Skip to main content

Hippocratic AI

Category: AI in Healthcare

Hippocratic AI develops clinically safe generative AI agents for healthcare, focusing on non-diagnostic patient engagement and care management Hippocratic AI was founded in 2022. The company is led by Munjal Shah. Based in Palo Alto, United States. Team size: 180+. Total funding raised: $404 million. Latest round: Series C. Key investors include ["Avenir Growth (Lead)","Andreessen Horowitz","General Catalyst","Kleiner Perkins","Premji Invest","CapitalG","NVIDIA","SV Angel"].

Founded
2022
Headquarters
Palo Alto, United States
Team size
180+
Total funding
$404 million

Value proposition

Delivers AI agents with human-equivalent safety standards, addressing healthcare workforce shortages through scalable, clinically validated solutions with zero safety incidents in 115M+ patient interactions

Products and solutions

["Generative AI agents for chronic disease management","Polaris Safety Constellation Architecture (4.1T+ parameter specialized LLMs)","Patient engagement tools (post-discharge follow-up, appointment scheduling)","AI-driven operational workflows (documentation, care coordination)","Pharma-specific solutions for clinical trials and medication adherence"]

Unique value

First AI healthcare company with safety parity to human clinicians, co-founded by physicians and AI researchers, with 115M+ patient interactions and zero safety incidents

Target customer

Health systems, payors, pharmaceutical companies, and healthcare providers

Industries served

["Healthcare providers","Health insurance payors","Pharmaceutical companies","Hospital systems","Medicare Advantage plans"]

Technology advantage

Polaris 2.0 architecture uses 4.1T+ parameter constellation models with specialized support systems for medical accuracy, achieving zero safety incidents in 115M+ patient interactions

How they differentiate

Focus on safety-critical healthcare AI with clinical-grade LLMs, partnerships with major health systems during development, specialized agents for chronic disease management, and proven safety record with 115M+ interactions

Main competitors

["Apricot","Iodine Software","Notable Health","Suki AI"]

Key partnerships

["KPMG (healthcare delivery transformation)","Cleveland Clinic (clinical validation)","Cincinnati Children's Hospital (pediatric applications)","Universal Health Services (deployment)","NVIDIA (AI infrastructure)","Andreessen Horowitz and General Catalyst (investment ecosystem)"]

Notable customers

["Cleveland Clinic","Cincinnati Children's Hospital","Advocate Health","Universal Health Services","EUCALIA (Japan)"]

Major milestones

["Raised $404M total funding (2025, $3.5B valuation)","115M+ patient interactions with zero safety incidents","Partnerships with 50+ healthcare organizations across 6 countries","Developed 1000+ clinical use cases","Featured in Fortune 50 AI Innovators","First Japanese-language healthcare AI agent launch"]

Growth metrics

115M+ patient interactions with zero safety incidents, 50+ healthcare organization partnerships, 1000+ clinical use cases, 12x average ROI across different use cases

Market positioning

Positioned as the clinical AI partner for healthcare providers, emphasizing safety, regulatory compliance, and integration into existing workflows with demonstrated ROI

Geographic focus

Primarily U.S.-based with expansion into international markets including Japan through EUCALIA partnership

Patents and IP

Multiple pending patents for AI safety frameworks and multi-model medical reasoning systems

About Munjal Shah

Co-Founder and CEO of Hippocratic AI; previously co-founded Like.com (acquired by Google), Andale (sold to Alibaba), and Health IQ; serial entrepreneur in AI and healthcare with Master's in Computer Science from Stanford University

Official website: